Cyclacel Pharmaceuticals Announces Reverse Stock Split

BERKELEY HEIGHTS, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. CYCCCYCCP ", Cyclacel", or the ", Company", ))), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that it will implement a 1-for-15 Reverse Stock Split…#berkeleyheights #cyclacel #nasdaqcapitalmarket #cycc #reversestocksplit #equinititrustcompany #llc #cdk29 #plk1 #allrightsreserved
Source: Reuters: Health - Category: Consumer Health News Source Type: news